Background: Neurodermatitis is a chronic skin condition characterized by intense itching and skin thickening due to neurological dysfunction. Its persistent nature poses a challenge to effective treatment, significantly impacting patients' quality of life. Wet cupping therapy is increasingly being used in clinics to manage neurodermatitis, so it is imperative to assess the evidence regarding its effectiveness and safety.

Objective: This review aimed to evaluate the efficacy and safety of wet cupping therapy in patients with neurodermatitis.

Methods And Analysis: Randomized controlled trials (RCTs) investigating wet cupping for neurodermatitis were identified through searches of eight electronic databases and three clinical trial registration platforms from inception to March 2024, using predefined search terms. Included studies underwent quality appraisal using the Cochrane Collaboration's Risk of Bias Assessment tool. The quality of evidence was assessed independently by two reviewers using the Grading of Recommendations Assessment, Development, and Evaluation System (GRADE). Meta-analysis and publication bias assessment were conducted using ReviewManager 5.4 and STATA 17.0 software, respectively.

Results: This review encompassed 19 studies, comprising 6 types of comparisons and involving 1,505 participants. The findings revealed no significant difference in the total effective rate between wet cupping alone and high-potency steroids ( = 269, RR = 1.13, 95% CI [0.90, 1.41],  = 0.29, I = 83%). However, wet cupping combined with medication or moxibustion exhibited superior efficacy compared to medication alone ( = 272, RR = 1.28, 95% CI [1.16, 1.41],  < 0.00001, I = 43%) and ( = 534, RR = 1.22, 95% CI [1.14, 1.30],  < 0.00001, I = 0%). Wet cupping groups demonstrated lower recurrence rates ( = 266, RR = 0.31, 95% CI [0.16, 0.60],  = 0.0005, I = 0%) and a reduced incidence of adverse events ( = 673, RR = 0.44, 95% CI [0.21, 0.90],  = 0.02, I = 36%). Furthermore, wet cupping alone or combined with moxibustion effectively lowered the levels of inflammatory factors compared to medication: TNF- ( = 120, MD = -6.99, 95% CI [-8.13, -5.85],  < 0.00001, I = 0%), IL-1β ( = 120, MD = -5.28, 95% CI [-6.91, -3.65],  < 0.00001, I = 48%), and IL-6 ( = 180, MD = -8.61, 95% CI [-13.24, -3.99],  = 0.0003, I = 81%).

Conclusion: The efficacy of wet cupping therapy is comparable to that of high-potency steroids. Its combined use with medication or moxibustion appears to enhance effectiveness, reduce recurrence rates, and improve safety. However, due to the overall low grade of evidence for the identified outcomes and poor methodological quality, caution is advised when interpreting and applying these findings in clinical practice.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero, identifier: CRD42024524398.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693718PMC
http://dx.doi.org/10.3389/fmed.2024.1478073DOI Listing

Publication Analysis

Top Keywords

wet cupping
24
efficacy safety
8
safety wet
8
cupping therapy
8
bias assessment
8
wet
6
cupping
6
cupping treatment
4
neurodermatitis
4
treatment neurodermatitis
4

Similar Publications

Background: Neurodermatitis is a chronic skin condition characterized by intense itching and skin thickening due to neurological dysfunction. Its persistent nature poses a challenge to effective treatment, significantly impacting patients' quality of life. Wet cupping therapy is increasingly being used in clinics to manage neurodermatitis, so it is imperative to assess the evidence regarding its effectiveness and safety.

View Article and Find Full Text PDF

Background: Primary dysmenorrhea (PD) is characterized by discomfort with no organic etiology (no pelvic disease), recurring pain, or lower abdominal cramps that start between the first 8-72 h of menstruation. Cupping therapy uses a tool to form a vacuum at certain points on the skin.

Objectives: We investigated the mechanism of pain relief caused by cupping therapy in primary dysmenorrhea that is played by cupping therapy in PD.

View Article and Find Full Text PDF

Wet-Cupping's Impact on Pancreatitis Induced by Hypertriglyceridemia: A case study and brief literature review.

Sultan Qaboos Univ Med J

November 2024

Internal Medicine Residency Training Program, Oman Medical Specialty Board, Muscat, Oman.

Article Synopsis
  • Familial hypertriglyceridemia is a genetic disorder that causes high levels of triglycerides in the blood, which can lead to acute and chronic pancreatitis.
  • A 34-year-old male patient in Muscat, Oman, diagnosed with this condition experienced a significant reduction in triglycerides and a decrease in hospital admissions for pancreatitis after starting cupping therapy.
  • This case report suggests that cupping therapy may help manage familial hypertriglyceridemia and lower the risk of pancreatitis.
View Article and Find Full Text PDF

Objectives: Cupping therapy is a widely used complementary medicine for the treatment of migraine headaches globally. However, conflicting evidence exists on its effectiveness. To evaluate the safety and efficacy of cupping therapy in treating migraine headache disorder.

View Article and Find Full Text PDF

Wet-cupping therapy (WCT) is one of the oldest known medical techniques, used as a traditional and complementary therapy with a wide application all around the world for general health. Research on the effects of WCT on sports performance are sparse and inconsistent. Thus, we aimed to explore the effects of WCT on repeated sprint ability, wellness, and exertion in young active males.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!